186 related articles for article (PubMed ID: 16358638)
1. [Analog insulin preparations in patients with type 2 diabetes. Better rapid and brief than sluggish and long].
MMW Fortschr Med; 2005 Nov; 147(46):60. PubMed ID: 16358638
[No Abstract] [Full Text] [Related]
2. [Analog insulin requirements of the average patient. Interview by Dr. rer. nat. Anita Schweiger].
Renner MR
Fortschr Med; 1997 Apr; 115(10):8-10. PubMed ID: 9206690
[No Abstract] [Full Text] [Related]
3. Insuline glusine (Apidra): a new rapid-acting insulin.
Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
[TBL] [Abstract][Full Text] [Related]
4. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
5. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
[TBL] [Abstract][Full Text] [Related]
6. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
Westphal SA; Palumbo PJ
Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
[No Abstract] [Full Text] [Related]
8. Starting insulin strategies for patients with an inadequate response to oral therapy.
Rolla AR
Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():6-9. PubMed ID: 19817777
[No Abstract] [Full Text] [Related]
9. A dose range finding study of novel oral insulin (IN-105) under fed conditions in type 2 diabetes mellitus subjects.
Khedkar A; Iyer H; Anand A; Verma M; Krishnamurthy S; Savale S; Atignal A
Diabetes Obes Metab; 2010 Aug; 12(8):659-64. PubMed ID: 20590742
[TBL] [Abstract][Full Text] [Related]
10. [Thanks to fast acting insulin analogs, diabetes therapy without hourly schedule].
MMW Fortschr Med; 2002 Nov; 144(46):71. PubMed ID: 12534091
[No Abstract] [Full Text] [Related]
11. Premixed biphasic insulin analogs - a choice for pediatric patients with type 2 diabetes rather than type 1 diabetes?
Danne T
Pediatr Diabetes; 2006 Feb; 7(1):1-3. PubMed ID: 16489967
[No Abstract] [Full Text] [Related]
12. U-500 insulin: why, when and how to use in clinical practice.
Garg R; Johnston V; McNally PG; Davies MJ; Lawrence IG
Diabetes Metab Res Rev; 2007 May; 23(4):265-8. PubMed ID: 17109474
[TBL] [Abstract][Full Text] [Related]
13. Starting insulin therapy in type 2 diabetes: lesson 2.
McCall AL
Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
[No Abstract] [Full Text] [Related]
14. [Insulin treatment of type 1 diabetes in adults].
Birkeland KI
Tidsskr Nor Laegeforen; 2006 Mar; 126(6):776-8. PubMed ID: 16541173
[No Abstract] [Full Text] [Related]
15. Insulin glargine: cornerstone treatment for type 2 diabetes patients. Introduction.
Garg SK
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():1-4. PubMed ID: 18577151
[No Abstract] [Full Text] [Related]
16. The importance of titrating starting insulin regimens in patients with type 2 diabetes.
Garber AJ
Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():10-3. PubMed ID: 19817778
[No Abstract] [Full Text] [Related]
17. Clinical update on Humalog Mix25 a novel pre-mixed formulation of insulin lispro and NPL.
Herz M
Int J Clin Pract Suppl; 1999 Jul; 104():8-13; discussion 18-20. PubMed ID: 12669732
[No Abstract] [Full Text] [Related]
18. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
19. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
Koenen C
Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):E1. PubMed ID: 18806804
[No Abstract] [Full Text] [Related]
20. [Clinical use of long-acting insulin analogs].
Birkeland KI
Tidsskr Nor Laegeforen; 2006 Apr; 126(8):1067-8. PubMed ID: 16619068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
